Highlights of 2022 EHA Congress – Myeloproliferative Neoplasms

Myeloproliferative Neoplasms (MPNs) are clonal hematopoietic stem cell disorders that have a proliferative nature and a variable tendency to transform into myelofibrosis and acute leukemia. In addition to symptom relief and prevention of thromboembolic as well as bleeding events, the treatment goal of disease modification has become increasingly important in recent years. We summarize two abstracts focusing on the treatment of Poly-cythemia vera (PV) and Primary Myelofibrosis (PMF).